Skip to content

Fluorescence In Situ Hybridization Solutions

From automated hybridization workflows to targeted probe detection, supporting precise molecular diagnostics.

SingPath provides fluorescence in situ hybridization solutions covering automated FISH processing, probe-based detection, workflow support, and digital fluorescence imaging.

Designed for molecular pathology, hematology, oncology, and research laboratories, our FISH solutions help standardize complex hybridization procedures and support the detection of gene rearrangements, amplifications, deletions, and chromosomal abnormalities.

Integrated Solutions for the FISH Testing

Reliable FISH testing depends on both standardized sample processing and high-quality probe reagents. SingPath combines automated FISH instrumentation with a broad probe portfolio to support laboratories across pretreatment, hybridization, washing, signal detection, and result interpretation.

FISH Workflow

Sample Preparation

Sample Pretreatment

Denaturation

Hybridization

Washing

Counterstaining

Fluorescence Imaging

Signal Interpretation

01

Sample Preparation

Tissue, cytology, or hematological samples are prepared on glass slides according to the test protocol.

02

Pretreatment

Slides undergo appropriate preparation to improve probe accessibility to the target DNA.

03

Denaturation

Target DNA and probe DNA are denatured to allow sequence-specific binding.

04

Hybridization

Fluorescently labelled probes bind to complementary DNA sequences within the sample.

05

Washing

Unbound probe is removed through controlled post-hybridization washing.

06

Counterstaining

Nuclear counterstaining, commonly using DAPI, helps visualize cell nuclei.

07

Fluorescence Imaging

Slides are examined using fluorescence microscopy or digital fluorescence scanning.

08

Signal Interpretation

Signal patterns are assessed to identify relevant genomic abnormalities.

FISH Probe Portfolio

Targeted Probes for Molecular Diagnosis

SingPath FISH instrument

SingPath offers FISH probe solutions supporting the detection of clinically relevant genetic abnormalities across hematology, solid tumors, and precision oncology applications.

The portfolio includes probes for gene rearrangements, translocations, amplifications, deletions, and chromosomal abnormalities.

Hematological Malignancies

Hematological cells illustration

Supporting molecular characterization of leukemia, lymphoma, and myeloid neoplasms

FISH probes can support detection of chromosomal and gene-level abnormalities associated with hematological malignancies:

  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Chronic Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasms
  • Lymphoma
  • Plasma Cell Disorders
Breast cancer illustration with a highlighted tumour region

Breast Cancer

Supporting HER2 and related molecular assessment

FISH can be used in selected breast cancer workflows to assess gene amplification and support biomarker evaluation.

Common application

  • HER2 amplification assessment
Lung cancer illustration with a highlighted tumour region

Lung Cancer

Targeted detection of clinically relevant gene rearrangements

FISH probes can support molecular evaluation of selected genomic abnormalities in lung cancer.

Potential applications

  • ALK rearrangement
  • ROS1 rearrangement
  • MET-related abnormalities
  • Other clinically relevant targets depending on probe availability
Urological anatomy illustration with a highlighted bladder region

Urological & Genitourinary Tumors

Chromosomal and gene abnormality assessment for selected tumor applications

FISH can support selected diagnostic and research applications in urinary and genitourinary pathology.

Histology section of soft tissue

Soft Tissue & Sarcoma

Gene rearrangement detection for tumor classification

FISH is widely used in selected sarcoma and soft tissue tumor workflows where specific gene rearrangements may support diagnosis.

Fluorescence microscopy image of a tumour region

Other Solid Tumors

FISH may support molecular assessment across additional tumor types where amplification, deletion, translocation, or rearrangement status is diagnostically relevant.

Probe Types

Fluorescence in situ hybridization probe signals along a DNA strand

Break-Apart Probes

Designed to detect rearrangements involving a specific gene locus without requiring prior knowledge of the fusion partner.

Typical use: Gene rearrangement detection.

Dual-Fusion Probes

Designed to identify specific translocations involving two known genes.

Typical use: Fusion gene detection.

Amplification Probes

Used to assess increases in gene copy number.

Typical use: Gene amplification analysis.

Deletion Probes

Used to identify loss of specific chromosomal regions or gene loci.

Typical use: Deletion analysis.

Enumeration Probes

Used to assess chromosome copy number.

Typical use: Aneuploidy and chromosomal abnormality evaluation.